Home/Investors/Apple Tree Partners

Apple Tree Partners

Biotech Investor · 2 portfolio companies

Portfolio

2

Combined Value

$854.5M

Focus Areas

5

Top Stage

Phase 1

Investment Focus

Cardiovascular Fibrotic Diseases Metabolic Diseases Oncology Ophthalmology

Portfolio Companies

Company	Stage	Valuation	Focus
Tectonic Therapeutic	Phase 1	$561.0M	Cardiovascular, Fibrotic Diseases
Foghorn Therapeutics	Phase 1	$293.5M	Oncology, Ophthalmology

Frequent Co-Investors

Atlas Venture1 shared RA Capital Management1 shared Bain Capital Life Sciences1 shared OrbiMed1 shared Polaris Partners1 shared Surveyor Capital (a Citadel company)1 shared Lilly (via collaboration)1 shared Merck (via collaboration)1 shared